Breakthrough Study led by Edgar Engleman Identifies Key Immune Switch That Could Revolutionize Treatments for Autoimmunity and other diseases

Written by Diana L Sung

Researchers discover how erythropoietin (EPO) signaling in dendritic cells (cDC1s) regulates immune tolerance, offering new pathways for treating diseases like diabetes and other autoimmune conditions.


Diana L Sung
Previous

SDRC members highlighted in the new "Walk with Me" video series
Next

Type 1 Diabetes Cured in Groundbreaking Study with mice by SDRC investigators